{"actionType":"INHIBITOR","mechanismOfAction":"Proto-oncogene tyrosine-protein kinase ROS inhibitor","chemblIds":["CHEMBL1983268"],"targetName":"Proto-oncogene tyrosine-protein kinase ROS","targetType":"single protein","targets":["ENSG00000047936"],"references":[{"source":"FDA","ids":["label/2019/212725s000lbl.pdf","label/2019/212725s000lbl.pdf","label/2019/212725s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase Aurora-A inhibitor","chemblIds":["CHEMBL3545326"],"targetName":"Serine/threonine-protein kinase Aurora-A","targetType":"single protein","targets":["ENSG00000087586"],"references":[{"source":"Other","ids":["https://www.taihooncology.com/us/science/product-pipeline/"],"urls":["https://www.taihooncology.com/us/science/product-pipeline/"]},{"source":"DOI","ids":["10.1158/1535-7163.TARG-13-A268"],"urls":["http://mct.aacrjournals.org/content/12/11_Supplement/A268"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Glycoprotein inhibitor","chemblIds":["CHEMBL1743061"],"targetName":"Glycoprotein","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["15994800"],"urls":["http://europepmc.org/abstract/MED/15994800"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL90983"],"references":[{"source":"PubMed","ids":["21107289"],"urls":["http://europepmc.org/abstract/MED/21107289"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Antibodies hydrolytic enzyme","chemblIds":["CHEMBL4297981"],"references":[{"source":"EMA","ids":["https://www.ema.europa.eu/en/documents/product-information/idefirix-epar-product-information_en.pdf"],"urls":["https://www.ema.europa.eu/en/documents/product-information/idefirix-epar-product-information_en.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Beta-2 adrenergic receptor antagonist","chemblIds":["CHEMBL1201063","CHEMBL631"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"Wikipedia","ids":["Sodium_channel"],"urls":["http://en.wikipedia.org/wiki/Sodium_channel"]},{"source":"DailyMed","ids":["setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08","setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08","setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d4a552ce-f215-4ec7-b5dd-aee266ba9b08"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA (cytosine-5)-methyltransferase 1 inhibitor","chemblIds":["CHEMBL1201129"],"targetName":"DNA (cytosine-5)-methyltransferase 1","targetType":"single protein","targets":["ENSG00000130816"],"references":[{"source":"Wikipedia","ids":["DNA_methylation","DNA_methylation","DNA_methylation"],"urls":["http://en.wikipedia.org/wiki/DNA_methylation","http://en.wikipedia.org/wiki/DNA_methylation","http://en.wikipedia.org/wiki/DNA_methylation"]},{"source":"DailyMed","ids":["setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2#section-13"]}]}
{"mechanismOfAction":"Glutathione precursor","chemblIds":["CHEMBL600"],"references":[{"source":"PubMed","ids":["18046889","2546864","26855777"],"urls":["http://europepmc.org/abstract/MED/18046889","http://europepmc.org/abstract/MED/2546864","http://europepmc.org/abstract/MED/26855777"]},{"source":"FDA","ids":["label/2004/21539_N-acetylcysteine_lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21539_N-acetylcysteine_lbl.pdf"]},{"source":"DailyMed","ids":["archives/fdaDrugInfo.cfm?archiveid=323452","archives/fdaDrugInfo.cfm?archiveid=323452","archives/fdaDrugInfo.cfm?archiveid=438110"],"urls":["https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=323452","https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=323452","https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=438110"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase AKT inhibitor","chemblIds":["CHEMBL2325741"],"targetName":"Serine/threonine-protein kinase AKT","targetType":"protein family","targets":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"references":[]}
{"actionType":"INHIBITOR","mechanismOfAction":"Telomerase reverse transcriptase inhibitor","chemblIds":["CHEMBL2107856"],"targetName":"Telomerase reverse transcriptase","targetType":"single protein","targets":["ENSG00000164362"],"references":[{"source":"PubMed","ids":["20048334","27192120"],"urls":["http://europepmc.org/abstract/MED/20048334","http://europepmc.org/abstract/MED/27192120"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Prostatic acid phosphatase binding agent","chemblIds":["CHEMBL1237024"],"targetName":"Prostatic acid phosphatase","targetType":"single protein","targets":["ENSG00000014257"],"references":[{"source":"FDA","ids":["https://www.fda.gov/media/78511/download"],"urls":["https://www.fda.gov/media/78511/download"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H3 receptor antagonist","chemblIds":["CHEMBL3545030"],"targetName":"Histamine H3 receptor","targetType":"single protein","targets":["ENSG00000101180"],"references":[{"source":"PubMed","ids":["22931528"],"urls":["http://europepmc.org/abstract/MED/22931528"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Sodium channel protein type IX alpha subunit blocker","chemblIds":["CHEMBL3545091"],"targetName":"Sodium channel protein type IX alpha subunit","targetType":"single protein","targets":["ENSG00000169432"],"references":[{"source":"PubMed","ids":["25060923"],"urls":["http://europepmc.org/abstract/MED/25060923"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Dihydrofolate reductase inhibitor","chemblIds":["CHEMBL3989825","CHEMBL747"],"targetName":"Dihydrofolate reductase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["10348748"],"urls":["http://europepmc.org/abstract/MED/10348748"]},{"source":"Wikipedia","ids":["Cycloguanil"],"urls":["http://en.wikipedia.org/wiki/Cycloguanil"]}]}
{"actionType":"ANTISENSE INHIBITOR","mechanismOfAction":"Clusterin mRNA antisense inhibitor","chemblIds":["CHEMBL2108309"],"targetName":"Clusterin mRNA","targetType":"nucleic-acid","targets":["ENSG00000120885"],"references":[{"source":"PubMed","ids":["23130925","23266703","23836992"],"urls":["http://europepmc.org/abstract/MED/23130925","http://europepmc.org/abstract/MED/23266703","http://europepmc.org/abstract/MED/23836992"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Calcitonin gene-related peptide type 1 receptor antagonist","chemblIds":["CHEMBL3334624"],"targetName":"Calcitonin gene-related peptide type 1 receptor","targetType":"single protein","targets":["ENSG00000064989"],"references":[{"source":"PubMed","ids":["21172952"],"urls":["http://europepmc.org/abstract/MED/21172952"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Vasopressin V2 receptor antagonist","chemblIds":["CHEMBL344159"],"targetName":"Vasopressin V2 receptor","targetType":"single protein","targets":["ENSG00000126895"],"references":[{"source":"DailyMed","ids":["setid=5526617c-c7b9-4556-886d-729bbabbc566"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5526617c-c7b9-4556-886d-729bbabbc566"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cyclooxygenase inhibitor","chemblIds":["CHEMBL1528134","CHEMBL12610"],"targetName":"Cyclooxygenase","targetType":"protein family","targets":["ENSG00000073756","ENSG00000095303"],"references":[{"source":"PubMed","ids":["1287137","19883251","25729498","26006195","27108819","28127472","4044146","7600413"],"urls":["http://europepmc.org/abstract/MED/1287137","http://europepmc.org/abstract/MED/19883251","http://europepmc.org/abstract/MED/25729498","http://europepmc.org/abstract/MED/26006195","http://europepmc.org/abstract/MED/27108819","http://europepmc.org/abstract/MED/28127472","http://europepmc.org/abstract/MED/4044146","http://europepmc.org/abstract/MED/7600413"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Phosphodiesterase 3A inhibitor","chemblIds":["CHEMBL799"],"targetName":"Phosphodiesterase 3A","targetType":"single protein","targets":["ENSG00000172572"],"references":[{"source":"DailyMed","ids":["setid=ada307f1-b6b1-4b64-a060-5c254b1948f2"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ada307f1-b6b1-4b64-a060-5c254b1948f2"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Voltage-gated L-type calcium channel blocker","chemblIds":["CHEMBL452076"],"targetName":"Voltage-gated L-type calcium channel","targetType":"protein family","targets":["ENSG00000151067","ENSG00000081248","ENSG00000157388","ENSG00000102001"],"references":[{"source":"PubMed","ids":["24407539"],"urls":["http://europepmc.org/abstract/MED/24407539"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Dihydrofolate reductase inhibitor","chemblIds":["CHEMBL2218878","CHEMBL119"],"targetName":"Dihydrofolate reductase","targetType":"single protein","targets":[],"references":[{"source":"DailyMed","ids":["setid=ad0f8925-f817-4460-aa6b-172a043a440b"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad0f8925-f817-4460-aa6b-172a043a440b"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Dopamine transporter inhibitor","chemblIds":["CHEMBL796"],"targetName":"Dopamine transporter","targetType":"single protein","targets":["ENSG00000142319"],"references":[{"source":"DailyMed","ids":["setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1","setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd#nlm34090-1"]},{"source":"PubMed","ids":["23284812","23284812"],"urls":["http://europepmc.org/abstract/MED/23284812","http://europepmc.org/abstract/MED/23284812"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Ghrelin receptor agonist","chemblIds":["CHEMBL2105872","CHEMBL13817"],"targetName":"Ghrelin receptor","targetType":"single protein","targets":["ENSG00000121853"],"references":[{"source":"PubMed","ids":["11452249","18056963"],"urls":["http://europepmc.org/abstract/MED/11452249","http://europepmc.org/abstract/MED/18056963"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase BTK inhibitor","chemblIds":["CHEMBL4163691"],"targetName":"Tyrosine-protein kinase BTK","targetType":"single protein","targets":["ENSG00000010671"],"references":[{"source":"ClinicalTrials","ids":["NCT01765478"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT01765478"]},{"source":"PubMed","ids":["28950886"],"urls":["http://europepmc.org/abstract/MED/28950886"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Glucagon-like peptide 1 receptor agonist","chemblIds":["CHEMBL2107860"],"targetName":"Glucagon-like peptide 1 receptor","targetType":"single protein","targets":["ENSG00000112164"],"references":[{"source":"PubMed","ids":["21114599","23139373"],"urls":["http://europepmc.org/abstract/MED/21114599","http://europepmc.org/abstract/MED/23139373"]}]}
{"actionType":"POSITIVE MODULATOR","mechanismOfAction":"Survival motor neuron protein positive modulator","chemblIds":["CHEMBL4297240"],"targetName":"Survival motor neuron protein","targetType":"single protein","targets":["ENSG00000172062","ENSG00000205571"],"references":[{"source":"FDA","ids":["https://www.fda.gov/media/126109/download"],"urls":["https://www.fda.gov/media/126109/download"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Vasopressin V1a receptor antagonist","chemblIds":["CHEMBL1201108","CHEMBL1755"],"targetName":"Vasopressin V1a receptor","targetType":"single protein","targets":["ENSG00000166148"],"references":[{"source":"FDA","ids":["label/2012/021697s003lbl.pdf","label/2012/021697s003lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021697s003lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021697s003lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Interleukin-8 receptor B antagonist","chemblIds":["CHEMBL2178579"],"targetName":"Interleukin-8 receptor B","targetType":"single protein","targets":["ENSG00000180871"],"references":[{"source":"PubMed","ids":["21426372"],"urls":["http://europepmc.org/abstract/MED/21426372"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase SYK inhibitor","chemblIds":["CHEMBL4116008"],"targetName":"Tyrosine-protein kinase SYK","targetType":"single protein","targets":["ENSG00000165025"],"references":[{"source":"Other","ids":["https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/","https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/","https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/"],"urls":["https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/","https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/","https://www.portola.com/clinical-development/cerdulatinib-dual-syk-jak-inhibitor/l-development/cerdulatinib-dual-syk-jak-inhibitor/"]},{"source":"PubMed","ids":["25253883","25253883","25253883","25253883"],"urls":["http://europepmc.org/abstract/MED/25253883","http://europepmc.org/abstract/MED/25253883","http://europepmc.org/abstract/MED/25253883","http://europepmc.org/abstract/MED/25253883"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Dopamine D2 receptor modulator","chemblIds":["CHEMBL3545388"],"targetName":"Dopamine D2 receptor","targetType":"single protein","targets":["ENSG00000149295"],"references":[{"source":"PubMed","ids":["24817271"],"urls":["http://europepmc.org/abstract/MED/24817271"]},{"source":"Other","ids":["https://gupea.ub.gu.se/bitstream/2077/7535/2/Thesis_Johan_Rung.pdf"],"urls":["https://gupea.ub.gu.se/bitstream/2077/7535/2/Thesis_Johan_Rung.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serotonin transporter inhibitor","chemblIds":["CHEMBL1708","CHEMBL490"],"targetName":"Serotonin transporter","targetType":"single protein","targets":["ENSG00000108576"],"references":[{"source":"DailyMed","ids":["setid=d8a896c2-b0c2-4b44-a4e3-cb6a8ea472ee#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d8a896c2-b0c2-4b44-a4e3-cb6a8ea472ee#nlm34090-1"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"High mannose oligosaccharides hydrolytic enzyme","chemblIds":["CHEMBL4298010"],"references":[{"source":"EMA","ids":["https://www.ema.europa.eu/en/documents/product-information/lamzede-epar-product-information_en.pdf"],"urls":["https://www.ema.europa.eu/en/documents/product-information/lamzede-epar-product-information_en.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cytotoxic T-lymphocyte protein 4 inhibitor","chemblIds":["CHEMBL2108658"],"targetName":"Cytotoxic T-lymphocyte protein 4","targetType":"single protein","targets":["ENSG00000163599"],"references":[{"source":"PubMed","ids":["22437870","27042127"],"urls":["http://europepmc.org/abstract/MED/22437870","http://europepmc.org/abstract/MED/27042127"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Nischarin agonist","chemblIds":["CHEMBL19236"],"targetName":"Nischarin","targetType":"single protein","targets":["ENSG00000010322"],"references":[{"source":"PubMed","ids":["21884003","22483786","24302832"],"urls":["http://europepmc.org/abstract/MED/21884003","http://europepmc.org/abstract/MED/22483786","http://europepmc.org/abstract/MED/24302832"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Angiopoietin-2 inhibitor","chemblIds":["CHEMBL2108678"],"targetName":"Angiopoietin-2","targetType":"single protein","targets":["ENSG00000091879"],"references":[{"source":"PubMed","ids":["23149917","26490310"],"urls":["http://europepmc.org/abstract/MED/23149917","http://europepmc.org/abstract/MED/26490310"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Galectin-1 inhibitor","chemblIds":["CHEMBL4297960"],"targetName":"Galectin-1","targetType":"single protein","targets":["ENSG00000100097"],"references":[{"source":"Other","ids":["https://investor.galectintherapeutics.com/news-releases/news-release-details/pro-pharmaceuticals-announces-significant-advance-defining","https://investor.galectintherapeutics.com/news-releases/news-release-details/pro-pharmaceuticals-announces-significant-advance-defining"],"urls":["https://investor.galectintherapeutics.com/news-releases/news-release-details/pro-pharmaceuticals-announces-significant-advance-defining","https://investor.galectintherapeutics.com/news-releases/news-release-details/pro-pharmaceuticals-announces-significant-advance-defining"]},{"source":"PubMed","ids":["29320431","29320431"],"urls":["http://europepmc.org/abstract/MED/29320431","http://europepmc.org/abstract/MED/29320431"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Methionine aminopeptidase 2 inhibitor","chemblIds":["CHEMBL4297651"],"targetName":"Methionine aminopeptidase 2","targetType":"single protein","targets":["ENSG00000111142"],"references":[{"source":"ClinicalTrials","ids":["NCT03254368"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT03254368"]},{"source":"PubMed","ids":["29491038"],"urls":["http://europepmc.org/abstract/MED/29491038"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial dihydropteroate synthase inhibitor","chemblIds":["CHEMBL1191"],"targetName":"Bacterial dihydropteroate synthase","targetType":"single protein","targets":[],"references":[{"source":"KEGG","ids":["D00870"],"urls":["http://www.kegg.jp/dbget-bin/www_bget?dr:D00870"]},{"source":"PubMed","ids":["2372557"],"urls":["http://europepmc.org/abstract/MED/2372557"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA topoisomerase I inhibitor","chemblIds":["CHEMBL3989514","CHEMBL481"],"targetName":"DNA topoisomerase I","targetType":"single protein","targets":["ENSG00000198900"],"references":[{"source":"DailyMed","ids":["setid=80f3b79c-a399-45b3-b755-8535457719af"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80f3b79c-a399-45b3-b755-8535457719af"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tumor susceptibility gene 101 protein inhibitor","chemblIds":["CHEMBL2109593"],"targetName":"Tumor susceptibility gene 101 protein","targetType":"single protein","targets":["ENSG00000074319"],"references":[{"source":"Other","ids":["http://www.dtic.mil/docs/citations/ADA607997"],"urls":["http://www.dtic.mil/docs/citations/ADA607997"]},{"source":"PubMed","ids":["27622299"],"urls":["http://europepmc.org/abstract/MED/27622299"]}]}
{"mechanismOfAction":"Supplement","chemblIds":["CHEMBL1705709"],"references":[{"source":"BNF","ids":["https://bnf.nice.org.uk/drug/sodium-feredetate.html"],"urls":["https://bnf.nice.org.uk/drug/sodium-feredetate.html"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Nonstructural protein 5A inhibitor","chemblIds":["CHEMBL3545062"],"targetName":"Nonstructural protein 5A","targetType":"single protein","targets":[],"references":[{"source":"FDA","ids":["label/2016/208341s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serotonin transporter inhibitor","chemblIds":["CHEMBL1200492","CHEMBL623"],"targetName":"Serotonin transporter","targetType":"single protein","targets":["ENSG00000108576"],"references":[{"source":"DailyMed","ids":["setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1","setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1","setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1","setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b1d149db-ad43-4f3f-aef1-fb0395ba4191#nlm34090-1"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Muscarinic acetylcholine receptor M3 antagonist","chemblIds":["CHEMBL1200891","CHEMBL1495"],"targetName":"Muscarinic acetylcholine receptor M3","targetType":"single protein","targets":["ENSG00000133019"],"references":[{"source":"ISBN","ids":["9780702034718 PP. 153","9780702034718 PP. 153"],"urls":["http://www.isbnsearch.org/isbn/9780702034718","http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"PubMed","ids":["14168823","14492109","14168823","14492109"],"urls":["http://europepmc.org/abstract/MED/14168823","http://europepmc.org/abstract/MED/14492109","http://europepmc.org/abstract/MED/14168823","http://europepmc.org/abstract/MED/14492109"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"ALK tyrosine kinase receptor inhibitor","chemblIds":["CHEMBL2403108"],"targetName":"ALK tyrosine kinase receptor","targetType":"single protein","targets":["ENSG00000171094"],"references":[{"source":"FDA","ids":["label/2014/205755s000lbl.pdf","label/2017/205755s009lbl.pdf","label/2017/205755s009lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205755s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205755s009lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Platelet activating factor receptor antagonist","chemblIds":["CHEMBL2110618"],"targetName":"Platelet activating factor receptor","targetType":"single protein","targets":["ENSG00000169403"],"references":[{"source":"PubMed","ids":["1663352"],"urls":["http://europepmc.org/abstract/MED/1663352"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase Aurora-A inhibitor","chemblIds":["CHEMBL52885"],"targetName":"Serine/threonine-protein kinase Aurora-A","targetType":"single protein","targets":["ENSG00000087586"],"references":[{"source":"Other","ids":["http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf"],"urls":["http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf","http://www.casipharmaceuticals.com/files/enmd_corporate_april_2008.pdf"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Lewis Y antigen binding agent","chemblIds":["CHEMBL2109306"],"references":[{"source":"PMC","ids":["PMC5530862"],"urls":["http://europepmc.org/articles/PMC5530862"]},{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/canres/51/14/3781.full.pdf"],"urls":["http://cancerres.aacrjournals.org/content/canres/51/14/3781.full.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Dual specificity mitogen-activated protein kinase kinase 1 inhibitor","chemblIds":["CHEMBL1615025"],"targetName":"Dual specificity mitogen-activated protein kinase kinase 1","targetType":"single protein","targets":["ENSG00000169032"],"references":[{"source":"PubMed","ids":["21310613","23587417","21310613","23587417"],"urls":["http://europepmc.org/abstract/MED/21310613","http://europepmc.org/abstract/MED/23587417","http://europepmc.org/abstract/MED/21310613","http://europepmc.org/abstract/MED/23587417"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase SRC inhibitor","chemblIds":["CHEMBL571546"],"targetName":"Tyrosine-protein kinase SRC","targetType":"single protein","targets":["ENSG00000197122"],"references":[{"source":"DOI","ids":["10.1158/1538-7445.AM10-2487"],"urls":["http://cancerres.aacrjournals.org/content/70/8_Supplement/2487"]},{"source":"PubMed","ids":["21509526","23361621"],"urls":["http://europepmc.org/abstract/MED/21509526","http://europepmc.org/abstract/MED/23361621"]},{"source":"Other","ids":["http://www.kinexpharma.com/drug-pipeline/kx01/"],"urls":["http://www.kinexpharma.com/drug-pipeline/kx01/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"D2-like dopamine receptor agonist","chemblIds":["CHEMBL1303"],"targetName":"D2-like dopamine receptor","targetType":"protein family","targets":["ENSG00000149295","ENSG00000151577","ENSG00000069696"],"references":[{"source":"FDA","ids":["label/2012/021829s001lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021829s001lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Lysosomal alpha-glucosidase inhibitor","chemblIds":["CHEMBL1561"],"targetName":"Lysosomal alpha-glucosidase","targetType":"single protein","targets":["ENSG00000171298"],"references":[{"source":"DailyMed","ids":["setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1","setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75711d16-2d27-476e-a312-d5af448a0e25#nlm34090-1"]},{"source":"PubMed","ids":["23185202","23185202"],"urls":["http://europepmc.org/abstract/MED/23185202","http://europepmc.org/abstract/MED/23185202"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cyclin-dependent kinase 9 inhibitor","chemblIds":["CHEMBL3545283"],"targetName":"Cyclin-dependent kinase 9","targetType":"single protein","targets":["ENSG00000136807"],"references":[{"source":"PubMed","ids":["17363486","25215591","17363486","25215591","17363486","25215591"],"urls":["http://europepmc.org/abstract/MED/17363486","http://europepmc.org/abstract/MED/25215591","http://europepmc.org/abstract/MED/17363486","http://europepmc.org/abstract/MED/25215591","http://europepmc.org/abstract/MED/17363486","http://europepmc.org/abstract/MED/25215591"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","chemblIds":["CHEMBL2110732"],"targetName":"Epidermal growth factor receptor erbB1","targetType":"single protein","targets":["ENSG00000146648"],"references":[{"source":"Other","ids":["https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf","https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf","https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"],"urls":["https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf","https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf","https://www.pfizer.com/files/news/esmo/dacomitinib_fact_sheet.pdf"]},{"source":"PubMed","ids":["18089823","18089823","18089823"],"urls":["http://europepmc.org/abstract/MED/18089823","http://europepmc.org/abstract/MED/18089823","http://europepmc.org/abstract/MED/18089823"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Xanthine dehydrogenase inhibitor","chemblIds":["CHEMBL1467"],"targetName":"Xanthine dehydrogenase","targetType":"single protein","targets":["ENSG00000158125"],"references":[{"source":"FDA","ids":["label/2000/020298Orig1s001.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/020298Orig1s001.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","chemblIds":["CHEMBL3545299"],"targetName":"Hepatocyte growth factor receptor","targetType":"single protein","targets":["ENSG00000105976"],"references":[{"source":"Other","ids":["http://mct.aacrjournals.org/content/6/11_Supplement/B258.short"],"urls":["http://mct.aacrjournals.org/content/6/11_Supplement/B258.short"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"T-cell surface glycoprotein CD5 binding agent","chemblIds":["CHEMBL2108785"],"targetName":"T-cell surface glycoprotein CD5","targetType":"single protein","targets":["ENSG00000110448"],"references":[{"source":"PubMed","ids":["2013915"],"urls":["http://europepmc.org/abstract/MED/2013915"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA topoisomerase I inhibitor","chemblIds":["CHEMBL2108470"],"targetName":"DNA topoisomerase I","targetType":"single protein","targets":["ENSG00000198900"],"references":[{"source":"PubMed","ids":["15187995","29372102"],"urls":["http://europepmc.org/abstract/MED/15187995","http://europepmc.org/abstract/MED/29372102"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase Chk1 inhibitor","chemblIds":["CHEMBL2041933"],"targetName":"Serine/threonine-protein kinase Chk1","targetType":"single protein","targets":["ENSG00000149554"],"references":[{"source":"Other","ids":["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7762/"],"urls":["http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7762/"]},{"source":"PubMed","ids":["18790776","19568282"],"urls":["http://europepmc.org/abstract/MED/18790776","http://europepmc.org/abstract/MED/19568282"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Peroxisome proliferator-activated receptor alpha agonist","chemblIds":["CHEMBL519504"],"targetName":"Peroxisome proliferator-activated receptor alpha","targetType":"single protein","targets":["ENSG00000186951"],"references":[{"source":"PubMed","ids":["1438286","1486069"],"urls":["http://europepmc.org/abstract/MED/1438286","http://europepmc.org/abstract/MED/1486069"]},{"source":"Wikipedia","ids":["Aleglitazar","Aleglitazar"],"urls":["http://en.wikipedia.org/wiki/Aleglitazar","http://en.wikipedia.org/wiki/Aleglitazar"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Interleukin-1 alpha inhibitor","chemblIds":["CHEMBL4594518"],"targetName":"Interleukin-1 alpha","targetType":"single protein","targets":["ENSG00000115008"],"references":[{"source":"PubMed","ids":["30552176","30653843","30552176","30653843"],"urls":["http://europepmc.org/abstract/MED/30552176","http://europepmc.org/abstract/MED/30653843","http://europepmc.org/abstract/MED/30552176","http://europepmc.org/abstract/MED/30653843"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Serotonin 1b (5-HT1b) receptor antagonist","chemblIds":["CHEMBL3183740"],"targetName":"Serotonin 1b (5-HT1b) receptor","targetType":"single protein","targets":["ENSG00000135312"],"references":[{"source":"PubMed","ids":["10996601","11504649","10996601","11504649"],"urls":["http://europepmc.org/abstract/MED/10996601","http://europepmc.org/abstract/MED/11504649","http://europepmc.org/abstract/MED/10996601","http://europepmc.org/abstract/MED/11504649"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Platelet-derived growth factor receptor beta inhibitor","chemblIds":["CHEMBL403989"],"targetName":"Platelet-derived growth factor receptor beta","targetType":"single protein","targets":["ENSG00000113721"],"references":[{"source":"PubMed","ids":["18483622","18311895","18330892","18483622","18311895","18330892","18483622","18311895","18330892","18483622","18311895","18330892","18483622","18311895","18330892","18483622","18311895","18330892","18483622"],"urls":["http://europepmc.org/abstract/MED/18483622","http://europepmc.org/abstract/MED/18311895","http://europepmc.org/abstract/MED/18330892","http://europepmc.org/abstract/MED/18483622","http://europepmc.org/abstract/MED/18311895","http://europepmc.org/abstract/MED/18330892","http://europepmc.org/abstract/MED/18483622","http://europepmc.org/abstract/MED/18311895","http://europepmc.org/abstract/MED/18330892","http://europepmc.org/abstract/MED/18483622","http://europepmc.org/abstract/MED/18311895","http://europepmc.org/abstract/MED/18330892","http://europepmc.org/abstract/MED/18483622","http://europepmc.org/abstract/MED/18311895","http://europepmc.org/abstract/MED/18330892","http://europepmc.org/abstract/MED/18483622","http://europepmc.org/abstract/MED/18311895","http://europepmc.org/abstract/MED/18330892","http://europepmc.org/abstract/MED/18483622"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Interleukin-8 receptor B modulator","chemblIds":["CHEMBL189475"],"targetName":"Interleukin-8 receptor B","targetType":"single protein","targets":["ENSG00000180871"],"references":[{"source":"PubMed","ids":["21718305","21718305"],"urls":["http://europepmc.org/abstract/MED/21718305","http://europepmc.org/abstract/MED/21718305"]}]}
